Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUCE DAPT Duration With COMBO Dual-therapy Stent in Acute Coronary Syndrome
2013-005571-40Phase 4Active
- Sponsor
- Diagram B.V.
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aspirin in acute coronary syndrome (ACS) and Non-ST-segment elevation myocardial infarction (NSTEMI) (2 arms), sponsored by Diagram B.V. Primary endpoint: Composite safety and efficacy endpoint at 360 days. Started Jan 2014; status: active.
02
Drugs
aspirin
03
Conditions
acute coronary syndrome (ACS)Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on 2013-005571-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005571-40.